145 related articles for article (PubMed ID: 30773665)
1. Haemorrhagic gastric hyperplastic polyps associated with long-term use of proton pump inhibitor in a case without Helicobacter pylori infection.
Kinoshita S; Nishizawa T; Mori H; Kikuchi M
J Clin Pharm Ther; 2019 Jun; 44(3):493. PubMed ID: 30773665
[No Abstract] [Full Text] [Related]
2. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors.
Gao W; Huang Y; Lu S; Li C
Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
5. Experimental strategies for induction of gastric adenocarcinomas under long-term proton pump inhibitor administration and Helicobacter pylori infection.
Hagiwara T; Mukaisho K; Nakayama T; Sugihara H; Hattori T
Asian Pac J Cancer Prev; 2012; 13(6):3005-6. PubMed ID: 22938497
[No Abstract] [Full Text] [Related]
6. GASTRIC FUNDIC GLAND POLYPS: CAN HISTOLOGY BE USEFUL TO PREDICT PROTON PUMP INHIBITORS USE?
Brito HLF; Barros C; Freire MV; Silva Filho MND; Nascimento TV
Arq Gastroenterol; 2018; 55(4):380-384. PubMed ID: 30785522
[TBL] [Abstract][Full Text] [Related]
7. Sporadic fundic gland polyps are not associated with proton pump inhibitors therapy but negatively correlate with Helicobacter pylori infection in China.
Cao H; Qu R; Zhang Z; Kong X; Wang S; Jiang K; Wang B
Chin Med J (Engl); 2014; 127(7):1239-43. PubMed ID: 24709173
[TBL] [Abstract][Full Text] [Related]
8. The association between duration of and indications for proton pump inhibitor use and risk of gastric polyps.
Kroupa R; Pavlik T; Konecny S; Packova B; Dastych M; Pavlovsky Z; Dolina J
Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):829-835. PubMed ID: 37395234
[TBL] [Abstract][Full Text] [Related]
9. Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
Tsukamoto H; Mizoshita T; Sasaki M; Mizushima T; Tanida S; Ozeki K; Hirata Y; Shimura T; Kataoka H; Kamiya T; Nojiri S; Tsukamoto T; Tatematsu M; Joh T
Asian Pac J Cancer Prev; 2011; 12(4):1049-54. PubMed ID: 21790250
[TBL] [Abstract][Full Text] [Related]
10. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.
Arai J; Niikura R; Hayakawa Y; Aoki T; Yamada A; Kawai T; Fujishiro M
Gut; 2022 May; 71(5):1043-1044. PubMed ID: 34344784
[No Abstract] [Full Text] [Related]
11. Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps.
Nam SY; Park BJ; Ryu KH; Nam JH
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):449-54. PubMed ID: 26735158
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and gastric cancer: a population-based cohort study.
Patel J; Berezowski I; Janapala RN; Pourmand A
Gut; 2022 May; 71(5):1039-1041. PubMed ID: 34261754
[No Abstract] [Full Text] [Related]
13. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial.
Ohkusa T; Takashimizu I; Fujiki K; Suzuki S; Shimoi K; Horiuchi T; Sakurazawa T; Ariake K; Ishii K; Kumagai J; Tanizawa T
Ann Intern Med; 1998 Nov; 129(9):712-5. PubMed ID: 9841603
[TBL] [Abstract][Full Text] [Related]
14. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.
Ji F; Wang ZW; Ning JW; Wang QY; Chen JY; Li YM
World J Gastroenterol; 2006 Mar; 12(11):1770-3. PubMed ID: 16586550
[TBL] [Abstract][Full Text] [Related]
15. Relative risk factors associated with the development of fundic gland polyps.
Huang CZ; Lai RX; Mai L; Zhou HL; Chen HJ; Guo HX
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1217-21. PubMed ID: 25187299
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases.
Ohkusa T; Miwa H; Hojo M; Kumagai J; Tanizawa T; Asaoka D; Terai T; Ohkura R; Sato N
Digestion; 2003; 68(2-3):57-62. PubMed ID: 14581761
[TBL] [Abstract][Full Text] [Related]
17. [Cystic polyposis of the stomach (fundic gland polyps)--relationship to the absence of Helicobacter pylori infection and a therapy with drugs suppressing gastric acidity].
Fixa B; Vanásek T; Volfová M; Nozicka J; Nozicka Z
Cas Lek Cesk; 2012; 151(4):196-200. PubMed ID: 22679686
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Cronkhite-Canada syndrome showing resolution with Helicobacter pylori eradication and omeprazole].
Kim MS; Jung HK; Jung HS; Choi JY; Na YJ; Pyun GW; Ryu JH; Moon IH; Jo MS
Korean J Gastroenterol; 2006 Jan; 47(1):59-64. PubMed ID: 16434870
[TBL] [Abstract][Full Text] [Related]
19. Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for
Niikura R; Hayakawa Y; Hirata Y; Yamada A; Fujishiro M; Koike K
Gut; 2018 Oct; 67(10):1908-1910. PubMed ID: 29273641
[No Abstract] [Full Text] [Related]
20. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
